$SNOA SEC Filings

Filed On	Filing
06 Oct 2026	AMENDMENT TO FORM 8-A12B
06 Oct 2026	8-K: Entry into a Material Definitive Agreement; Material Modifications to Rights of Security Holders +1 more SECTION 382 RIGHTS AGREEMENT dated as of October 6, 2026 (the “Rights Agreement”), between SONOMA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and COMPUTERSHARE INC., as Rights Agent (the “Rights Agent”).
17 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders Our annual meeting of stockholders was held on September 16, 2026. Proxies were solicited pursuant to our definitive proxy statement filed on July 28, 2026 with the Securities and Exchange Commission under Section 14(a) of the Securities...
19 Aug 2026	8-K: Submission of Matters to a Vote of Security Holders
06 Aug 2026	FORM 10-Q FOR JUN 2026
28 Jul 2026	DEFINITIVE PROXY STATEMENT
23 Jul 2026	NOTICE OF ADJOURNMENT
09 Jul 2026	Form 4: Weigerstorfer Philippe, Director Granted 10,000 Stock option (right to buy)
09 Jul 2026	Form 4: Trombly Amy Moss, Chief Executive Officer Granted 10,000 Restricted Stock Units
09 Jul 2026	Form 4: Mclaughlin John, Director Granted 10,000 Stock option (right to buy)
09 Jul 2026	Form 4: Jacoby Vanessa, Director Granted 10,000 Stock option (right to buy)
09 Jul 2026	Form 4: Dvonch Jerome J, Chief Financial Officer Granted 10,000 Restricted Stock Units
09 Jul 2026	Form 4: Dal Poggetto John, Controller Granted 7,500 Restricted Stock Units
09 Jul 2026	FORM S-8
24 Jun 2026	FORM DEFA14A
18 Jun 2026	PROSPECTUS SUPPLEMENT
18 Jun 2026	8-K: Other Events
16 Jun 2026	FORM 10-K FOR MAR 2026
05 May 2026	Proxy statement: special meeting
30 Apr 2026	8-K: Entry into a Material Definitive Agreement; Other Events

Comments